ArticleCancer research2016

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma.

Jessica L F Teh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.